IS5288A - Vaccine preparations containing the FlgE polypeptide Helicobacter pylori - Google Patents

Vaccine preparations containing the FlgE polypeptide Helicobacter pylori

Info

Publication number
IS5288A
IS5288A IS5288A IS5288A IS5288A IS 5288 A IS5288 A IS 5288A IS 5288 A IS5288 A IS 5288A IS 5288 A IS5288 A IS 5288A IS 5288 A IS5288 A IS 5288A
Authority
IS
Iceland
Prior art keywords
helicobacter pylori
preparations containing
vaccine preparations
flge polypeptide
flge
Prior art date
Application number
IS5288A
Other languages
Icelandic (is)
Inventor
Berglindh Thomas
Mellgård Björn
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS5288A publication Critical patent/IS5288A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS5288A 1997-06-12 1999-12-08 Vaccine preparations containing the FlgE polypeptide Helicobacter pylori IS5288A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702242A SE9702242D0 (en) 1997-06-12 1997-06-12 Vaccine compositions V
PCT/SE1998/001093 WO1998056816A1 (en) 1997-06-12 1998-06-08 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE

Publications (1)

Publication Number Publication Date
IS5288A true IS5288A (en) 1999-12-08

Family

ID=20407351

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5288A IS5288A (en) 1997-06-12 1999-12-08 Vaccine preparations containing the FlgE polypeptide Helicobacter pylori

Country Status (21)

Country Link
EP (1) EP1009764A1 (en)
JP (1) JP2002507118A (en)
KR (1) KR20010013699A (en)
CN (1) CN1259960A (en)
AR (1) AR012896A1 (en)
AU (1) AU8048798A (en)
BR (1) BR9810026A (en)
CA (1) CA2293293A1 (en)
EE (1) EE9900566A (en)
HU (1) HUP0003164A3 (en)
ID (1) ID23052A (en)
IL (1) IL133144A0 (en)
IS (1) IS5288A (en)
NO (1) NO996132L (en)
NZ (1) NZ501427A (en)
PL (1) PL337503A1 (en)
SE (1) SE9702242D0 (en)
SK (1) SK173099A3 (en)
TR (1) TR199903060T2 (en)
WO (1) WO1998056816A1 (en)
ZA (1) ZA984696B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784687A (en) * 2015-04-27 2015-07-22 苏州大学附属第一医院 Application of flagellar hook protein FlgE of reorganized pseudomonas aeruginosa
CN113425717B (en) * 2021-04-22 2023-06-16 成都欧林生物科技股份有限公司 Medicament for improving efficacy of oral helicobacter pylori vaccine and application thereof
CN116535472B (en) * 2023-05-31 2024-04-30 四川大学华西医院 Helicobacter pylori recombinant protein antigen FlgK and preparation method and application thereof
CN118105473A (en) * 2024-04-30 2024-05-31 成都欧林生物科技股份有限公司 Oral immunogenic composition for preventing or treating Hp infection and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
AR003125A1 (en) * 1995-06-01 1998-07-08 Astra Ab BACTERIAL ANTIGENS FOR THE DIAGNOSIS OF INFECTIONS WITH HELICOBACTER PYLORI, A DNA MOLECLE THAT CODES IT, A VECTOR, A HOST CELL, A PROCEDURE FOR PRODUCING THE POLIPEPTIDE, USE OF ELEPIPETICO, AND PROAPILY USE

Also Published As

Publication number Publication date
JP2002507118A (en) 2002-03-05
HUP0003164A2 (en) 2000-12-28
AR012896A1 (en) 2000-11-22
CA2293293A1 (en) 1998-12-17
ZA984696B (en) 1999-01-04
EE9900566A (en) 2000-06-15
ID23052A (en) 2000-01-20
AU8048798A (en) 1998-12-30
KR20010013699A (en) 2001-02-26
CN1259960A (en) 2000-07-12
NO996132D0 (en) 1999-12-10
IL133144A0 (en) 2001-03-19
SE9702242D0 (en) 1997-06-12
HUP0003164A3 (en) 2001-10-29
NZ501427A (en) 2000-09-29
BR9810026A (en) 2000-09-19
TR199903060T2 (en) 2000-09-21
WO1998056816A1 (en) 1998-12-17
EP1009764A1 (en) 2000-06-21
SK173099A3 (en) 2000-06-12
NO996132L (en) 2000-01-28
PL337503A1 (en) 2000-08-28

Similar Documents

Publication Publication Date Title
IL142216A0 (en) A polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same
DE69722620D1 (en) NON-AQUEOUS PROTICAL PEPTIDE PREPARATIONS
IL143633A0 (en) Peptides containing ovarian carcinoma proteins and pharmaceutical compositions and vaccines containing the same
EE04481B1 (en) A peptide and adjuvant based pharmaceutical composition for immune modulation
EE9700306A (en) Helicobacter pylori antigens and vaccine mixtures
PL345541A1 (en) Antigenic peptides derived from telomerase
HUP9802889A3 (en) Percutaneous preparations comprising tulobuterol
EP0998942A4 (en) Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method
DE59707298D1 (en) DESODORING PREPARATIONS
IL138207A0 (en) Methods and devices for modulating the immune response
DK0925273T3 (en) Pharmaceutical preparations containing 4-oxo-butanoic acids
AU1698699A (en) (helicobacter pylori) vaccine formulations
GB9706930D0 (en) Leishmania vaccine
IS5288A (en) Vaccine preparations containing the FlgE polypeptide Helicobacter pylori
EE03511B1 (en) Prolonged release pharmaceutical preparations containing misolastin
PL343432A1 (en) Methods and devices for modulating the immune response
EP0888126A4 (en) Anti-idiotypic antibody vaccines
GB2331521B (en) Vaccine preparations
IL110954A0 (en) Pharmaceutical compositions comprising a retinoblastoma polypeptide or protein, and methods for the preparation and use thereof
NO981407D0 (en) Protein from Helicobacter pylori
EP1121937A4 (en) Vaccine preparations containing saponins
AU8048698A (en) Vaccine compositions comprising the (helicobacter pylori) pfr polypeptide
AU7945798A (en) Vaccine compositions comprising the (helicobacter pylori) 26kda polypeptide
IL115197A0 (en) Vaccine preparations
DE19880842D2 (en) Low-dose 15-deoxyspergualin preparations